Illumina Defends Validity Of DNA Sequencing Patents At Trial

By Hannah Albarazi · November 19, 2021, 10:09 PM EST

A California federal jury heard testimony Friday from gene sequencing company Illumina's expert witness that 10 judges who previously upheld Illumina's patents behind its next-generation technology "got it right," one day...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

Illumina, Inc. et al v. BGI Genomics Co., Ltd et al

Case Number

3:19-cv-03770

Court

California Northern

Nature of Suit

Patent

Date Filed

June 27, 2019